Skip to main navigation

AVLAYAH™ (tividenofusp alfa-eknm) is NOW APPROVED in the U.S. Learn more in our press release.

Investors & News
Contact Us

Investors & News
Contact Us

Science Overview

TransportVehicle™ Platform

Publications

Partnerships & Collaborations

Product & Pipeline

Product & Pipeline Overview

Product

Pipeline

Patients Overview

Our Commitment

Advocacy

Grants & Sponsorships

Therapeutic Areas

Clinical Studies

Early Access Program

Medical Professionals

Medical Professionals Overview

Get In Touch

Clinical Studies

Recent Publications

Grants & Sponsorships

Early Access Program

About Us overview

About Us

Leadership

Careers Overview

Life at Denali

Benefits &Offerings

Internships

Postdoc Program

STEM Outreach

TransportVehicle™ Platform
Publications
Partnerships & Collaborations

Product & Pipeline

Product
Pipeline

Our Commitment
Advocacy
Grants & Sponsorships
Therapeutic Areas
Clinical Studies
Early Access Program

Alzheimer's disease
Frontotemporal dementia (FTD)
Hunter syndrome (MPS II)
Parkinson's disease
Pompe Disease
Sanfilippo syndrome (MPS IIIA)

Medical Professionals

Get In Touch
Clinical Studies
Publications
Grants & Sponsorships
Early Access Program

About Us
Leadership

Life at Denali
Benefits & Offerings
Internships
Postdoc Program
STEM Outreach

Events

Overview
Press Releases
Events
SEC Filings
Corporate Governance
Analyst Coverage

Upcoming Events

More events are coming soon.

Past Events

BofA Securities Health Care Conference 2026

May 12, 2026 | 3:00 PM to 3:30 PM PDT

Register for webcast

AVLAYAH™ (tividenofusp alfa-eknm) FDA Approval Call

Mar 25, 2026 12:30 PM EDT

Register for webcast

AVLAYAH™ (tividenofusp alfa-eknm) FDA Approval Presentation 2.8 MB

Denali Analyst Call – 2026 WORLDSymposium™

Feb 5, 2026 12:30 PM PST

Register for webcast

DNLI_WORLD2026 Analyst Call Presentation 2.4 MB

DNLI WORLD 2026 Tividenodusp Alfa Platform Presentation 520.1 KB

DNLI WORLD 2026 Tividenofusp Alfa Sibling Pair Poster 670.8 KB

DNLI WORLD 2026 MPS II HEOR Poster 453.7 KB

DNLI WORLD 2026 MPS II Community Survey Poster 632.1 KB

DNLI WORLD 2026 DNL126 Platform Presentation 464.8 KB

DNLI WORLD 2026 DNL952 Ph1 Study Design Poster 1.9 MB

DNLI WORLD 2026 DNL952 Preclinical Poster 4.1 MB

Denali Therapeutics 2025 Investor Day

Dec 4, 2025 | 8:30 AM to 11:30 AM EST

Register for webcast

Denali Therapeutics 2025 Investor Day 11.7 MB

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox

Science

TransportVehicle™ Platform
Publications
Partnerships & Collaborations

Product & Pipeline

Product
Pipeline

Patients

Our Commitment
Advocacy
Grants & Sponsorships
Therapeutic Areas
Clinical Studies
Early Access Program

Medical Professionals

Get in Touch
Clinical Studies
Recent Publications
Grants & Sponsorships
Early Access Program

About Us

About Us
Leadership
Investors & News
Contact Us

Careers

Life at Denali
Benefits & Offerings
Internships
Postdoc Program
STEM Outreach

Legal

Privacy Policy
Terms of Use
Consumer Health Data Privacy Policy
Cookies Policy
California Compliance Declaration
Community Guidelines

© 2026 Denali Therapeutics